California AB575 mandates health insurance coverage for FDA-approved anti-obesity medications and intensive behavioral therapy without prior.

California AB575, the Obesity Prevention Treatment Parity Act, requires health insurance policies to cover FDA-approved anti-obesity medications and intensive behavioral therapy for obesity treatment without prior authorization. The act applies to policies issued, amended, or renewed after January 1, 2026, and includes coverage for at least one FDA-approved anti-obesity medication, such as glucagon-like peptide-1 receptor agonists (GLP-1RAs).

California AB575 mandates health insurance coverage for FDA-approved anti-obesity medications and intensive behavioral therapy without prior.

California AB575, the Obesity Prevention Treatment Parity Act, requires health insurance policies to cover FDA-approved anti-obesity medications and intensive behavioral therapy for obesity treatment without prior authorization. The act applies to policies issued, amended, or renewed after January 1, 2026, and includes coverage for at least one FDA-approved anti-obesity medication, such as glucagon-like peptide-1 receptor agonists (GLP-1RAs).